Cheryl Cohen to Vaccination
This is a "connection" page, showing publications Cheryl Cohen has written about Vaccination.
Connection Strength
5,221
-
Prioritization of risk groups for influenza vaccination in resource limited settings - A case study from South Africa. Vaccine. 2019 01 03; 37(1):25-33.
Score: 0,532
-
Effectiveness of the 13-valent pneumococcal conjugate vaccine against invasive pneumococcal disease in South African children: a case-control study. Lancet Glob Health. 2017 03; 5(3):e359-e369.
Score: 0,469
-
Knowledge, attitudes, and practices about influenza illness and vaccination: a cross-sectional survey in two South African communities. Influenza Other Respir Viruses. 2016 09; 10(5):421-8.
Score: 0,446
-
Recommendations pertaining to the use of influenza vaccines and influenza antiviral drugs, 2016. S Afr Med J. 2016 Feb 04; 106(3):251-3.
Score: 0,438
-
Effectiveness and knowledge, attitudes and practices of seasonal influenza vaccine in primary healthcare settings in South Africa, 2010-2013. Influenza Other Respir Viruses. 2015 May; 9(3):143-50.
Score: 0,416
-
A Potential Platform for Future Vaccine Trials Identifies a High Incidence of Symptomatic and Asymptomatic Influenza Infection Among Children Aged 6 to 23 Months in South Africa. J Infect Dis. 2025 Feb 20; 231(2):e328-e336.
Score: 0,205
-
Home-Based Testing as an Approach to Estimate Influenza Vaccine Effectiveness in South Africa, 2021-2022-A Pilot Study. Influenza Other Respir Viruses. 2024 12; 18(12):e70034.
Score: 0,202
-
An evaluation of an influenza vaccination campaign targeting pregnant women in 27 clinics in two provinces of South Africa, 2015 - 2018. BMC Health Serv Res. 2021 Sep 09; 21(1):941.
Score: 0,162
-
Estimated impact of the pneumococcal conjugate vaccine on pneumonia mortality in South Africa, 1999 through 2016: An ecological modelling study. PLoS Med. 2021 02; 18(2):e1003537.
Score: 0,155
-
A Retrospective observational cohort study of the effect of antenatal influenza vaccination on birth outcomes in Cape Town, South Africa, 2015-2016. Influenza Other Respir Viruses. 2021 07; 15(4):446-456.
Score: 0,154
-
A cost-effectiveness analysis of South Africa's seasonal influenza vaccination programme. Vaccine. 2021 01 08; 39(2):412-422.
Score: 0,153
-
Influenza economic burden among potential target risk groups for immunization in South Africa, 2013-2015. Vaccine. 2020 10 21; 38(45):7007-7014.
Score: 0,151
-
Influenza disease burden among potential target risk groups for immunization in South Africa, 2013-2015. Vaccine. 2020 06 02; 38(27):4288-4297.
Score: 0,147
-
Vaccinating Mothers to Protect Their Babies Against Influenza. J Infect Dis. 2020 01 01; 221(1):5-7.
Score: 0,144
-
Heterogeneity in influenza seasonality and vaccine effectiveness in Australia, Chile, New Zealand and South Africa: early estimates of the 2019 influenza season. Euro Surveill. 2019 Nov; 24(45).
Score: 0,142
-
Health and economic burden of influenza-associated illness in South Africa, 2013-2015. Influenza Other Respir Viruses. 2019 09; 13(5):484-495.
Score: 0,138
-
The cost-effectiveness of trivalent and quadrivalent influenza vaccination in communities in South Africa, Vietnam and Australia. Vaccine. 2018 02 08; 36(7):997-1007.
Score: 0,125
-
Effectiveness of seasonal influenza vaccination in community-dwelling elderly people: an individual participant data meta-analysis of test-negative design case-control studies. Lancet Respir Med. 2017 03; 5(3):200-211.
Score: 0,118
-
Estimating vaccine effectiveness in preventing laboratory-confirmed influenza in outpatient settings in South Africa, 2015. Influenza Other Respir Viruses. 2017 03; 11(2):177-181.
Score: 0,116
-
Temporal Patterns of Influenza A and B in Tropical and Temperate Countries: What Are the Lessons for Influenza Vaccination? PLoS One. 2016; 11(3):e0152310.
Score: 0,111
-
Trivalent and quadrivalent influenza vaccination effectiveness in Australia and South Africa: results from a modelling study. Influenza Other Respir Viruses. 2016 07; 10(4):324-32.
Score: 0,110
-
Measles outbreak in South Africa: epidemiology of laboratory-confirmed measles cases and assessment of intervention, 2009-2011. PLoS One. 2013; 8(2):e55682.
Score: 0,089
-
Vaccine effectiveness estimates, 2004-2005 mumps outbreak, England. Emerg Infect Dis. 2007 Jan; 13(1):12-7.
Score: 0,058
-
Estimating the cost-effectiveness of maternal vaccination and monoclonal antibodies for respiratory syncytial virus in Kenya and South Africa. BMC Med. 2023 03 31; 21(1):120.
Score: 0,045
-
Optimal age targeting for pneumococcal vaccination in older adults; a modelling study. Nat Commun. 2023 02 16; 14(1):888.
Score: 0,045
-
Use of seasonal influenza and pneumococcal polysaccharide vaccines in older adults to reduce COVID-19 mortality. Vaccine. 2020 07 22; 38(34):5398-5401.
Score: 0,037
-
A cost-effectiveness analysis of antenatal influenza vaccination among HIV-infected and HIV-uninfected pregnant women in South Africa. Vaccine. 2019 10 31; 37(46):6874-6884.
Score: 0,035
-
Hepatitis B sero-prevalence in children under 15 years of age in South Africa using residual samples from community-based febrile rash surveillance. PLoS One. 2019; 14(5):e0217415.
Score: 0,034
-
Influenza epidemiology and immunization during pregnancy: Final report of a World Health Organization working group. Vaccine. 2017 10 13; 35(43):5738-5750.
Score: 0,031
-
Case-control vaccine effectiveness studies: Data collection, analysis and reporting results. Vaccine. 2017 06 05; 35(25):3303-3308.
Score: 0,030
-
Case-control vaccine effectiveness studies: Preparation, design, and enrollment of cases and controls. Vaccine. 2017 06 05; 35(25):3295-3302.
Score: 0,030
-
Risk factors associated with hospitalisation for influenza-associated severe acute respiratory illness in South Africa: A case-population study. Vaccine. 2016 11 04; 34(46):5649-5655.
Score: 0,029
-
HIV Infection and the Epidemiology of Invasive Pneumococcal Disease (IPD) in South African Adults and Older Children Prior to the Introduction of a Pneumococcal Conjugate Vaccine (PCV). PLoS One. 2016; 11(2):e0149104.
Score: 0,027
-
Assessing the impact of pneumococcal conjugate vaccines on invasive pneumococcal disease using polymerase chain reaction-based surveillance: an experience from South Africa. BMC Infect Dis. 2015 Oct 26; 15:450.
Score: 0,027
-
Risk factors for invasive pneumococcal disease among children less than 5 years of age in a high HIV prevalence setting, South Africa, 2010 to 2012. Pediatr Infect Dis J. 2015 Jan; 34(1):27-34.
Score: 0,025
-
Introduction of pneumococcal conjugate vaccine into the public immunization program in South Africa: translating research into policy. Vaccine. 2012 Sep 07; 30 Suppl 3:C21-7.
Score: 0,022
-
Invasive disease due to Haemophilus influenzae serotype b ten years after routine vaccination, South Africa, 2003-2009. Vaccine. 2012 Jan 11; 30(3):565-71.
Score: 0,020